Syngene International Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

05 Dec 2022 | 03:59 PM

600.20
-3.10 (-0.51%)

  • Outperforms Index

    5.36%

    Return (1Y)

    Beaten S&P BSE Healthcare by 8.96%

  • More Volatile

    1.91%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.9%

  • Not so consistent

    6/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

682

682.25

508

508.10

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Syngene International Ltd has increased by 18.78% since past 3 Months

  • MF shareholding in Syngene International Ltd has increased by 71.6% since past 3 Months

  • Promoter shareholding in Syngene International Ltd has decreased by -7.72% since past 3 Months

  • FII shareholding in Syngene International Ltd has increased by 19.17% since past 1 Year

Loading...